Litigation Details for Shire Development LLC v. Rhodes Pharmaceuticals L.P. (D. Del. 2017)
✉ Email this page to a colleague
Shire Development LLC v. Rhodes Pharmaceuticals L.P. (D. Del. 2017)
Docket | ⤷ Try a Trial | Date Filed | 2017-12-20 |
Court | District Court, D. Delaware | Date Terminated | 2018-04-26 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | RE41,148; RE42,096 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Shire Development LLC v. Rhodes Pharmaceuticals L.P.
Details for Shire Development LLC v. Rhodes Pharmaceuticals L.P. (D. Del. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2017-12-20 | 1 | United States Patent Nos. RE41,148 (“the ’148 patent”) and RE42,096 (“the ’096 patent”), attached hereto… This is a civil action for patent infringement arising under the patent laws of the United States, …Plaintiff Shire LLC owns the ’148 patent. 17. The ’096 patent, entitled “Oral Pulsed Dose Drug…LLC owns the ’096 patent. 18. Pursuant to 21 U.S.C. § 355(b)(1), the patents in suit are listed…product claimed in the ’148 patent—before the expiration of the ’148 patent. 29. Upon information | External link to document | |
2018-04-26 | 27 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE41,148; RE42,096. (Attachments…2017 26 April 2018 1:17-cv-01840 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
2017-12-20 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE41,148; RE42,096. (fms) (Entered…2017 26 April 2018 1:17-cv-01840 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |